Skip to main content

Want a detailed portfolio tracker?

Voyager Therapeutics (VYGR) P/E (2015 - 2026)

Voyager Therapeutics (VYGR) P/E from Nov 11, 2015 to Jul 21, 2026. The TTM Voyager Therapeutics (VYGR) P/E is -1.54. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Voyager Therapeutics (VYGR)

YearP/EChange
2026-1.54-16.23%
2025-1.84-61.28%
2024-4.76-164.68%
20237.36-153.85%
2022-13.67+852.95%
2021-1.43-119.70%
20207.28-161.99%
2019-11.75+243.16%
2018-3.42-41.58%
2017-5.86-40.12%
2016-9.79+181.82%
2015-3.47N/A

Comparison Voyager Therapeutics (VYGR) P/E with competitors

Voyager Therapeutics (VYGR) P/E is -1.54.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.11%
NBYStablecoin Development Corp0.00-100.28%
ENLVEnlivex Ltd0.07-104.84%
FGENFibroGen Inc0.24-115.54%
CHRSCoherus Biosciences Inc0.85-154.93%
FBIOFortress Biotech Inc0.95-161.43%
ORMPOramed Pharmaceuticals Inc1.50-197.29%
AGENAgenus Inc3.01-294.82%
INVAInnoviva Inc3.15-304.16%
CRMDCorMedix Inc3.63-334.87%
CVACCureVac N.V.4.45-387.77%
GLPGGalapagos NV4.86-414.52%
SRPTSarepta Therapeutics Inc4.88-416.02%
ABEOAbeona Therapeutics Inc5.39-448.74%
ABUSArbutus Biopharma Corp5.60-462.21%
ZVRAZevra Therapeutics Inc5.89-481.09%
SPROSpero Therapeutics Inc6.23-503.17%
CGENCompugen Ltd6.31-508.71%
RIGLRigel Pharmaceuticals6.87-544.84%
SLXNSilexion Therapeutics Corp7.30-572.28%
OMEROmeros Corporation9.26-699.33%
AUPHAurinia Pharmaceuticals Inc9.58-720.45%
PLXProtalix BioTherapeutics Inc10.89-804.99%
ACADAcadia Pharmaceuticals Inc11.73-859.20%
TBPHTheravance Biopharma Inc12.26-893.75%
ADMAAdma Biologics Inc12.42-903.84%
HRMYHarmony Biosciences Holdings Inc13.82-994.60%
SABSSAB Biotherapeutics Inc14.14-1015.06%
NAGENiagen Bioscience Inc14.82-1059.20%
INCYIncyte Corp15.82-1124.22%
REGNRegeneron Pharmaceuticals Inc15.86-1126.42%
PBYIPuma Biotechnology Inc17.32-1220.87%
CPRXCatalyst Pharmaceuticals Inc17.44-1228.87%
EXELExelixis Inc17.54-1235.26%
TGTXTG Therapeutics Inc18.97-1327.70%
MDXGMimedx Group Inc20.55-1430.39%
XOMAXOMA Royalty Corp22.87-1580.75%
ARGXArgen X SE24.30-1672.89%
CTMXCytomX Therapeutics Inc24.82-1706.75%
XOMAOXOMA Royalty Corp25.34-1740.65%
HALOHalozyme Therapeutics Inc25.62-1758.70%
XOMAPXOMA Royalty Corp25.67-1761.71%
VRTXVertex Pharmaceuticals Inc27.99-1912.19%
RPRXRoyalty Pharma plc - Class A28.69-1957.03%
SLNOSoleno Therapeutics Inc29.02-1978.25%
ASNDAscendis Pharma A/S30.09-2047.53%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2554.16%
APLSApellis Pharmaceuticals Inc39.02-2625.97%
BMRNBiomarin Pharmaceutical Inc42.21-2832.51%
KRYSKrystal Biotech Inc45.34-3035.23%
ONCBeiGene Ltd69.54-4601.57%
PHARPharming Group N.V.75.03-4956.64%
TECHBio-Techne Corp101.96-6700.09%
VCELVericel Corp109.92-7215.56%
ALNYAlnylam Pharmaceuticals Inc117.96-7736.26%
GMABGenmab140.29-9181.47%
TLXTelix Pharmaceuticals Ltd162.15-10596.67%
CORTCorcept Therapeutics Inc212.86-13878.95%